|
|
Article: Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations.
- Article from:
- PR Newswire
- Article date:
- September 29, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DETROIT, Sept. 29 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced today that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug manufacturing operations. The decree provides a series of measures that, when satisfied, will permit Caraco to resume manufacturing and distributing those products that are manufactured in its Detroit area facilities. The Company is working expeditiously to satisfy the requirements of the decree and has already retained independent cGMP experts for review of the Company's operations and to facilitate a successful result.
Under ...
Related newspaper, magazine, and journal articles:
|
|
Article: Has added Caraco Pharmaceutical Laboratories ...
M2 Presswire;
January 30, 2008 ;
700+ words
... ... Strategies: Has added Caraco Pharmaceutical Laboratories Ltd. to their watch list ... s activity has brought Caraco Pharmaceutical Laboratories Ltd. on our radar. Caraco Pharmaceutical Laboratories Ltd. was up over 4% with ...
|
|